All News

A man with lung cancer shares how learning about his EGFR exon 20 insertion mutation soon after being diagnosed has allowed him to be aggressive when pursuing a cancer treatment tailored to his rare mutation.

Watch Dr. Jessica R. Bauman, from Fox Chase Cancer Center, discuss palliative care during the CURE Educated Patient Lung Cancer Summit.

A clinical trial recently kicked off to study the effects of combining the novel drug BBP-398 plus Lumakras in patients with lung cancer that harbors a KRAS G12 mutation.

Once seen as a malignancy resistant to typical treatments such as chemotherapy, metastatic kidney cancer has come a long way in the past 20 years.

Chest numbness following a mastectomy can be truly daunting, but patients with breast cancer don’t have to suffer in silence — and it may not be something they have to live with.

As a survivor, I always urged people to get cancer screenings, and now I’ve found myself advocating for the COVID-19 booster shots, too.

Childhood cancer survivors should be aware of any symptoms they experience during survivorship and communicate those with their care team.

Watch Dr. Hossein Borghaei, Dr. David Gerber, Dr. Aaron S. Mansfield and Dana M. Haagen answer questions on the management of advanced/metastatic disease during the CURE Educated Patient Lung Cancer Summit.

These results, which showed that a patient with inflammatory breast cancer may have an increased risk for brain metastases if certain factors are present, may alert patients and doctors to consider routine brain scans while they undergo treatment for their disease.

After my cancer diagnosis, my family moved to Florida, which upset me at first, but ended up being a good thing.

An FDA approval put Ki-67 scoring — which may predict tumor growth — in the spotlight, but what that means long term to patients depends on who you ask.

Watch Dana Haagen, from Fox Chase Cancer Center, discuss clinical trials and how patients can join them, during the CURE® Educated Patient® Lung Cancer Summit.

My trip to the White House to advocate for myself and other patients with cancer was an empowering and memorable experience.

An expert offers insight into the major treatment improvements over the past 20 years for early-stage and late-stage lung cancer.

There are ways to manage the fear of cancer recurrence, so it doesn’t become overwhelming or debilitating. Physicians like me and a network of resources are here to help.

Here are some tips on how I helped a friend who was recently diagnosed with breast cancer.

After a metastatic prostate cancer diagnosis, Robert Hollander decided to bring together his love of wine and his journey with cancer to create a foundation to support the research field.

Watch Dr. Aaron S. Mansfield, from Mayo Clinic, discuss the management of mesothelioma during the CURE Educated Patient Lung Cancer Summit.

Watch Dr. David Gerber, from UT Southwestern Medical Center, discuss antibody drug conjugates during the CURE Educated Patient Lung Cancer Summit.

I’ve had leukemia for 13 years, and don’t owe anyone an explanation why my hair is short, or my face looks puffy.

Watch Dr. Hossein Borghaei, Dr. Jared Weiss and Dr. Anne Chiang answer questions about early disease management during the CURE Educated Patient Lung Cancer Summit.

Investigators of an expanded clinical trial have administered an investigational CAR-T cell therapy to the first patient with blood cancer.

Patients with lung cancer must be educated about their disease in their native language to become better advocates for themselves, an expert explained.

I sent all my cancer scans to my pediatrician, who combined the power of science with the power of belief and helped me through the difficult time.

From Kevin Durant’s sneaker that is raising money for cancer to Khloe Kardashian’s urging people to check for moles and melanoma, here’s what’s happening in the cancer space this week.

Watch Dr. Anne Chiang, from Yale School of Medicine, discuss molecular testing and adjuvant targeted therapies during the CURE Educated Patient Lung Cancer Summit.

The CAR T Together initiative is geared toward improving the development of allogeneic CAR-T cell therapies for patients with cancer.

As PSA testing recommendations change and the debate surrounding testing continues, people with a high-risk of prostate cancer and their families need to stay informed.